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Reports outlining the association between gait and cognition in Parkinson’s disease (PD)
are limited because of methodological issues and a bias toward studying advanced disease.
This study examines the association between gait and cognition in 121 early PD who were
characterized according to motor phenotype, and 184 healthy older adults. Quantitative
gait was captured using a 7 m GAITrite walkway while walking for 2 min under single-task
conditions and described by five domains (pace, rhythm, variability, asymmetry, and pos-
tural control). Cognitive outcomes were summarized by six domains (attention, working
memory, visual memory, executive function, visuospatial function, and global cognition).
Partial correlations and multivariate linear regression were used to determine independent
associations for all participants and for PD tremor-dominant (TD) and postural instability and
gait disorder (PIGD) phenotypes, controlling for age, sex, and premorbid intelligence using
the national adult reading test. Cognitive and gait outcomes were significantly worse for
PD. Gait, but not cognitive outcomes, was selectively worse for the PIGD phenotype com-
pared withTD. Significant associations emerged for two gait domains for controls (pace and
postural control) and four gait domains for PD (pace, rhythm, variability, and postural con-
trol).The strongest correlation was for pace and attention for PD and controls. Associations
were not significant for participants with the TD phenotype. In early PD, the cognitive cor-
relates of gait are predominantly with fronto-executive functions, and are characterized by
the PIGD PD phenotype.These associations provide a basis for understanding the complex
role of cognition in parkinsonian gait.
Keywords: Parkinson’s disease, gait, cognition
INTRODUCTION
Gait disturbance is a cardinal feature of Parkinson’s disease (PD)
and manifests as one of the earliest symptoms. Although the ini-
tial effect of dopaminergic medication on gait is dramatic (Morris
et al., 1994), it attenuates over the course of the disease with the
most debilitating features of gait dysfunction such as festination,
freezing of gait, and falls staying refractory to medication. Dis-
ease progression is considered to be slower for people with PD
who present with tremor-dominant (TD) phenotype compared
with the postural instability and gait disorder (PIGD) phenotype
where greater decline is evident not just for gait but for cognitive
and other non-motor features (Alves et al., 2006; Burn et al., 2006).
Gait, which is considered a mostly automatic motor skill, is
impaired in PD and cognitive control and is required to com-
pensate for gait deficit (Yogev et al., 2005). This becomes difficult
to maintain as disease advances and gait impairment reaches a
threshold beyond which motor (or cognitive) compensation is no
longer effective. Because of this, the relationship between gait and
cognition in PD is clearly evident. The cognitive correlates of gait
are dominated by attention and executive function, which chiefly
correspond with gait velocity and stride length (Rochester et al.,
2004; Lord et al., 2010) although other associations have been
reported (Lord et al., 2011). Correlates are generally stronger in
PD compared to controls, and further strengthened for PD with
mild cognitive impairment (MCI) (Amboni et al., 2012) and also
in more advanced disease (Bohnen et al., 2013). Mechanistic and
imaging studies support a role for cognition in PD gait (Mail-
let et al., 2012), although as with behavioral research it has mostly
been conducted in advanced disease cohorts. In early PD, cognitive
impairment in attention, executive function, and working memory
is mediated via dopaminergic frontostriatal networks, and further
posterior cortical dysfunction, perhaps determined by cholinergic
deficits, are expressed as amnestic dysfunction (Yarnall et al., 2011;
Alves et al., 2013).
Recent evidence suggests that selective features of gait are
underpinned by neurochemical deficits also involved in deter-
mining cognitive function, such as cortical cholinergic function
(Rochester et al., 2012; Amboni et al., 2013; Bohnen et al., 2013).
Gait metrics may therefore act as sensitive biomarkers and have
utility in identifying and predicting cognitive risk factors in PD
as well as in healthy aging and dementias (Verghese et al., 2007;
Amboni et al., 2012; Hausdorff and Buchman, 2013). However, few
studies have taken a systematic approach using a comprehensive
range of gait and cognitive characteristics to explore the indepen-
dent and selective associations between these complex functions.
Gait and cognition are non-unitary constructs, and measurement
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tools need to reflect this diversity. The aim of this study was
to explore the associations between gait and cognition in early
PD using a comprehensive quantitative evaluation of gait. We
hypothesized that independent gait and cognitive characteristics
would show a specific rather than global pattern of association;
this would differ in PD and controls highlighting the predomi-
nant frontostriatal cognitive disturbance present in early PD; and
the association would become stronger in PIGD cohort because
of shared pathological risk factors for faster rate of motor and
cognitive decline.
METHOD
PARTICIPANTS
People with PD were recruited within 4 months of diagnosis of
idiopathic PD as part of an incident cohort study [incidence of
cognitive impairment in cohorts with longitudinal evaluation –
Parkinson’s disease (ICICLE-PD)] conducted between June 2009
and December 2011(Khoo et al., 2013). PD was diagnosed by
a movement disorders specialist according to the UK Parkin-
son’s Disease Brain Bank criteria (Gibb and Lees, 1988) and were
excluded if they presented with memory impairment [mini men-
tal state exam (MMSE) ≤24] (Folstein et al., 1975), dementia
with Lewy bodies, drug induced parkinsonism, “vascular” parkin-
sonism, progressive supranuclear palsy, multiple system atrophy,
cortico-basal degeneration, or poor command of English.
To provide a comparison with normal aging and to generate
normative values for cognitive tests, controls of similar age and
sex to patients were recruited from community sources. Inclusion
criteria were (1) >60 years of age; (2) able to walk independently
without a walking aid; and (3) no significant cognitive impair-
ment, mood, or movement disorder. The study was approved by
the Newcastle and North Tyneside Research Ethics Committee and
all participants gave informed consent. Clinical testing took place
1 h after medication intake to ensure optimal function. Full details
of the recruitment process are described elsewhere (Khoo et al.,
2013).
Clinical assessment
Age, sex, and national adult reading test (NART) (Nelson, 1982)
were reported. Disease severity was measured using the movement
disorder society (MDS)-revised united Parkinson’s disease rating
scale (UPDRS) (Goetz et al., 2008) and TD and PIGD phenotypes
derived from UPDRS scores (Stebbins et al., 2013). For the timed
chair stand (a proxy for bradykinesia and muscle strength), par-
ticipants were asked to stand up from a seated position with arms
folded across their chest and sit down five times, as quickly as
possible (Podsiadlo and Richardson, 1991). Balance self-efficacy
was measured using the activities balance self confidence scale
(Powell and Myers, 1995), depression with the geriatric depres-
sion scale (Schrag et al., 2007), and physical fatigue was measured
with the multidimensional fatigue inventory (Smets et al., 1995).
Levodopa equivalent daily dose (LEDD) scores were calculated for
each patient (Tomlinson et al., 2010).
Gait assessment and outcomes
Gait was assessed using a 7 m long× 0.6 m wide instrumented
walkway (Platinum model Gaitrite, software version 4.5, CIR
systems, USA) under single-task conditions. Participants were
instructed to walk at their comfortable walking pace for 2 min
around a 25 m oval circuit (Galna et al., 2013). To aid interpreta-
tion of gait outcomes, we used a model of gait that we developed
for older adults and subsequently validated in PD. The model
comprises 16 gait variables describing 5 independent domains of
gait: pace (step velocity, mean step length, swing time variability),
rhythm (step time, swing time, stance time), variability (step veloc-
ity variability, step length variability, step time variability, stance
time variability), asymmetry (swing time asymmetry, step time
asymmetry, stance time asymmetry), and postural control (step
length asymmetry, mean step width, step width variability) (Lord
et al., 2013a).
Cognitive function
Six domains of cognition were assessed including global cognition,
which was measured with the MoCA (Nasreddine et al., 2005).
For the five remaining domains, neuropsychological tests were
selected according to earlier work (Rochester et al., 2004; Lord
et al., 2010) and extended to include other cognitive functions
we hypothesized to relate to gait. Individual test scores for neu-
ropsychological tests were converted to z scores relative to the
control cohort and combined into compound scores (mean of z
scores) for the following domains: attention was assessed by the
mean of simple reaction time, choice reaction time, and digit vigi-
lance time using the cognitive drug research (CDR) computerized
battery (Wesnes, 2002) and also fluctuating attention was mea-
sured using the CV of the same variables for descriptive purposes
only. We explored fluctuating attention in descriptive analysis as a
core cognitive function, which is sensitive to age-related cognitive
decline (Salthouse, 1996b) and a characteristic of dementia seen in
PD (Emre, 2003). Because of the high correlation between atten-
tion and fluctuating attention we combined these two domains
for subsequent analysis. Visual memory was measured with spatial
recognition memory (SRM), pattern recognition memory (PRM),
and paired associates learning (PAL) tasks from the computerized
CANTAB battery (Robbins et al., 1994). Executive function was
assessed with the modified one touch stockings (OTS) version of
the Tower of London task from CANTAB (Robbins et al., 1994),
and also included measures of response inhibition, learning, and
task switching from Hayling and Brixton (Burgess and Shallice,
1997), phoenemic fluency (words beginning with “F” in 1 min)
(Benton, 1968), and semantic fluency (animals in 90 s) (Good-
glass and Kaplan, 1972). Visuospatial function was measured using
a composite score of intersecting pentagons from the MMSE (Fol-
stein et al., 1975), which was scored on a three point scale (Ala et al.,
2001), and item 1 from the Montreal cognitive assessment (MoCA)
(trail making A, cube copying, and clock drawing) (Nasreddine
et al., 2005). Working memory was assessed using the forward digit
span from the Wechsler adult intelligence scale (Wechsler, 1958).
Data analysis
Univariate and bivariate analyses were used to describe the data,
which were inspected for normality and transformed where
required. PD participants were grouped into TD and PIGD phe-
notypes [data from indeterminate (ID) participants (n= 13) were
not analyzed] (Goetz et al., 2008). Student’s t-test and Chi-square
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Table 1 | Clinical characteristics for all participants.
Characteristic Controls (n=184) PD (n=121) P* TD (n=53) PIGD (n=55) P
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Male/female (n) 78/106 81/40 <0.001 31/22 40/18 0.156
Age (years) 69.4 (7.7) 67.0 (10.4) 0.024 66.1 (12.1) 67.3 (8.8) 0.575
Height (m) 1.67 (0.09) 1.69 (0.08) 0.046 1.69 (0.08) 1.70 (0.08) 0.637
NART 116.9 (7.6) 114.9 (11.0) 0.071 115.0 (11.0) 114.5(11.7) 0.825
LEDD (mg day−1) – 124.6 (146.0) – 145.9 (155.5) 212.4 (131.0) 0.018
UPDRS III – 25.5 (10.4) – 25.9 (10.3) 23.6 (10.3) 0.244
Hoehn and Yahr stage I (28); II (72); III (21) – I (18); II (34); III (1) I (9); II (29); III (17) <0.0001
Sit to stand 12.4 (3.9) 13.7 (4.2) 0.173 13.3 (4.7) 13.6 (3.9) 0.750
ABCs (0–100) 91.8 (10.9) 82.5 (18.9) <0.001 85.9 (17.6) 81.0 (18.6) 0.162
MFI–total fatigue (0–100) 38.1 (13.8) 49.9 (17.4) <0.001 44.9 (15.8) 52.4 (17.2) 0.022
GDS (0–15) 1.1 (1.8) 2.6 (2.1) <0.001 2.2 (2.3) 2.8 (2.0) 0.176
NART, national adults reading test; LEDD, levodopa daily dose equivalent; UPDRS III, united Parkinson’s disease rating scale; ABCs, activities balance
confidence-specific scale; MFI, multidimensional fatigue inventory; GDS, geriatric depression scale.
*Student’s t-test apart from sex (Chi-square).
test were used to examine difference between control and PD par-
ticipants and between PIGD and TD for all outcomes, including
all gait characteristics. Scores for cognitive and gait domains were
calculated so that positive values indicate better function. Asso-
ciations between cognitive and gait domains were first examined
using partial correlations, controlling for age, sex, and NART. In
preliminary analysis, we included height as a covariate but this
did not influence findings and was not included in subsequent
analysis.
Multivariate linear regression analysis. Multivariate linear
regression analysis further identified independent associations
between gait and cognitive domains for controls, PD participants,
and TD and PIGD motor phenotype. For Modela, five indepen-
dent models were examined, with each gait domain entered as
the dependent variable (pace, rhythm, asymmetry, variability, and
postural control) and independent variables entered in two stages.
Age, sex, and NART scores were entered in the first block and
all cognitive domains other than global cognition were entered as
the second group using a stepwise procedure. For Modelb, five
gait domains were again entered as dependent variables; however,
for this analysis only global cognition (MoCA) was entered as the
cognitive variable. MoCA was of interest because it defines MCI
(Level I) in PD (Litvan et al., 2012), and because global cogni-
tion has been shown to have a selective effect on gait in older
adults (Watson et al., 2010). Univariate, bivariate, and regression
data were examined for distribution, skewness, and residuals to
ensure assumptions of normality were not violated. Due to the
exploratory nature of study and limited sample size for pheno-
type analysis the alpha level was set at 0.05. SPSS v 21 was used to
analyze the data.
RESULTS
Incidence of cognitive impairment in cohorts with longitudinal
evaluation – Parkinson’s disease identified 165 incident PD cases
of which 150 were referred to ICICLE-GAIT. Consent was obtained
for 127 participants and 121 were accepted for baseline assessment.
The average age of the 29 ICICLE-PD participants (18 men and
11 women) who did not take part was 67.8 and 71.1 years, respec-
tively. Control participants (n= 184) were significantly older and
there were more females. PD participants in this newly diagnosed
cohort presented with mild to moderate PD, with most classified
as H&Y I and II (n= 100; 82.6%). With respect to motor pheno-
type, 55 (45.4%) were classified as TD and 53 (43.9%) as PIGD.
Compared to controls, PD participants were more fatigued and
depressed and had lower scores for balance self-efficacy. NART
scores were not significantly different (Table 1).
GAIT OUTCOMES: EFFECT OF PATHOLOGY AND MOTOR PHENOTYPE
All gait variables apart from step velocity variability, swing time,
and step width were significantly different between controls
and PD participants. PD participants walked more slowly, with
increased asymmetry, reduced step length, and overall a more
variable gait. Gait outcomes were also worse for PIGD partici-
pants who walked with a significantly slower, more variable gait,
and with a shorter step length compared to TD. For PIGD, 5 of
the 16 gait characteristics were significantly worse: gait speed, step
length, step time variability, swing time variability, and stance time
variability (Table 2).
COGNITIVE OUTCOMES: EFFECT OF PATHOLOGY AND MOTOR
PHENOTYPE
Scores for global cognition (MoCA) were significantly worse
for PD (P < 0.001) but no different between phenotypes. Cog-
nitive outcomes were significantly worse for PD compared to
controls apart from choice reaction time and reaction time vari-
ability. Between-group differences for reaction time and Brixton
score were significant but not as strong as other significant find-
ings (P = 0.029 and 0.020, respectively). Intersecting pentagons
reached a ceiling effect for both groups with only 16 (8.7%) con-
trol participants and 12 (9.9%) PD participants scoring fewer
than the maximum of two points. Cognitive scores did not dif-
fer significantly for motor phenotype apart from semantic fluency
(P = 0.046) with lower scores for the PIGD phenotype (Table 3).
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Table 2 | Gait characteristics for all participants and for PIGD andTD motor phenotype.
Gait domain and characteristics Controls (n=184) PD (n=121) P TD (n=53) PIGD (n=55) P
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Pace
Step velocity (m·s−1) 1.26 (0.19) 1.12 (0.21) <0.001 1.19 (0.20) 1.08 (0.20) 0.005
Step length (m) 0.67 (0.08) 0.62 (0.10) <0.001 0.65 (0.09) 0.59 (0.09) 0.002
Swing time variability (ms) 15.1 (5.4) 17.6 (6.0) <0.001 15.8 (5.4) 18.7 (6.3) 0.007
Rhythm
Mean step time (ms) 536.9 (46.9) 560.2 (48.4) <0.001 555.2 (45.1) 559.3 (50.9) 0.662
Mean swing time (ms) 386.7 (30.1) 391.5 (32.9) 0.190 393.5 (30.5) 387.9 (34.0) 0.373
Mean stance time (ms) 687.6 (71.6) 729.4 (76.6) <0.001 717.7 (71.8) 730.9 (80.3) 0.373
Variability
Step velocity variability (m·s−1) 0.052 (0.012) 0.054 (0.017) 0.413 0.052 (0.013) 0.055 (0.002) 0.421
Step length variability (m) 0.019 (0.005) 0.022 (0.008) <0.001 0.021 (0.007) 0.023 (0.007) 0.187
Step time variability (ms) 16.3 (5.7) 19.0 (6.6) <0.001 17.3 (6.2) 19.8 (6.6) 0.032
Stance time variability (ms) 19.6 (8.1) 23.4 (10.09) <0.001 21.1 (9.2) 24.7 (10.2) 0.038
Asymmetry
Swing time asymmetry (ms) 8.9 (9.4) 17.2 (20.1) <0.001 14.0 (13.3) 21.6 (25.7) 0.071
Step time asymmetry (ms) 11.2 (10.7) 22.6(27.4) <0.001 18.8 (17.5) 26.6 (34.8) 0.371
Stance time asymmetry (ms) 8.8 (9.3) 16.8 (19.7) <0.001 14.3 (12.6) 20.7 (25.3) 0.220
Postural control
Step length asymmetry (m) 0.020 (0.016) 0.026 (022) 0.014 0.022 (0.020) 0.028 (0.024) 0.153
Mean step width (m) 0.089 (0.024) 0.094 (0.030) 0.365 0.088 (0.027) 0.096 (0.032) 0.159
Step width variability (m) 0.022 (0.005) 0.018 (0.005) <0.001 0.018 (0.009) 0.019 (0.006) 0.294
Table 3 | Neuropsychological characteristics for all participants and for PIGD andTD motor phenotype.
Neuropsychological test Controls (n=184) PD (n=121) P TD (n=53) PIGD (n=55) P
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Global cognition
MoCA (n=89 controls, n=115 PD) 27.1 (2.4) 25.1 (3.5) <0.001 25.2 (3.7) 25.2 (3.2) 0.999
Working memory
Forward digit span 6.1 (1.2) 5.7 (1.1) 0.004 5.9 (1.1) 5.6 (1.1) 0.136
Power of attention 1303.3 (155.9) 1357.0 (200.6) 0.010 1341.3 (163.3) 1352.6 (228.1) 0.984
Reaction time (mean) 326.3 (63.7) 347.1 (101.1) 0.029 336.8 (57.4) 352.1 (135.1) 0.458
Choice reaction time (mean) 521.7 (73.9) 528.9 (84.0) 0.436 527.2 (83.4) 479.4 (56.3) 0.701
Digit vigilance (mean) 456.2 (50.9) 480.9 (56.9) <0.001 477.2 (55.7) 479.4 (56.3) 0.843
Fluctuating attention
Reaction time (CV) (%) 16.9 (5.1) 16.6 (4.5) 0.598 58.6 (22.0) 53.9 (19.6) 0.258
Choice reaction time (CV) (%) 17.7 (3.6) 18.9 (3.8) 0.008 101.8 (34.1) 100.4 (33.6) 0.831
Digit vigilance (CV) (%) 14.7 (4.1) 16.1 (3.7) 0.004 76.9 (22.9) 77.1 (21.6) 0.975
Executive function
One touch stocking (problems solved) 15.9 (3.1) 14.0 (4.3) <0.001 14.6 (3.4) 14.2 (4.1) 0.594
Semantic fluency (number of animals in 90 s) 24.2 (6.0) 21.5 (6.5) 0.002 23.2 (7.2) 20.8 (5.1) 0.046
Hayling score 5.9 (1.5) 5.2 (1.6) 0.001 5.3 (1.6) 5.2 (1.7) 0.796
Brixton score 5.2 (1.9) 4.5 (2.3) 0.020 4.4 (2.3) 4.6 (2.4) 0.749
Memory
Pattern recognition memory (number correct) 20.8 (2.3) 19.9 (2.7) 0.013 20.2 (2.7) 19.6 (2.6) 0.272
Spatial recognition memory (number correct) 16.2 (1.9) 15.4 (2.1) 0.002 15.8 (2.1) 15.1 (2.0) 0.107
Paired associate learning (mean trials to success) 1.8 (0.54) 2.1 (0.84) 0.006 2.0 (0.72) 2.1 (0.91) 0.997
Visuospatial
Pentagon copying 1.9 (0.2) 1.8 (0.34) 0.067 1.8 (0.34) 1.9 (0.22) 0.078
MoCA item 1 4.4 (0.65) 4.0 (1.1) 0.005 4.1 (1.2) 4.2(1.1) 0.678
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ASSOCIATIONS BETWEEN GAIT AND COGNITION
Effect of pathology
Associations between gait and cognition for controls, PD, and
PIGD groups are shown in Table 4 (partial correlations), Table 5
(multivariate regression analysis), and Figure 1 (residual plots
adjusted for age, sex, and NART for attention and pace for all par-
ticipants, and associated β-values). Partial correlations identified
cognitive correlates for four gait domains in PD (including PIGD)
and two gait domains in controls. Multivariate linear regression
analyses for PD and controls show an association between faster
pace and higher scores for attention, with the same amount of total
Table 4 | Partial correlations for cognitive and gait domains for all
participants.
Controls (n=184) PD (n=121) PIGD (n=55)
Pace 0.31
(P <0.001) A
0.36
(P <0.001) A
0.43
(P =0.003) A
0.23
(P <0.001) EF
0.20
(P =0.038) EF
0.23
(P =0.002) VM
0.28
(P =0.004) WM
0.21
(P =0.027) VS
Rhythm −0.37
(P =0.010) EF
Asymmetry
Variability 0.21
(P =0.024) GC
Postural
control
0.17
(P =0.018) A
0.30
(P =0.001) WM
0.32
(P =0.029) WM
Significant associations only: age, sex, and NART included as covariates.
EF, executive function; A, attention; WM, working memory; VS, visuospatial; GC,
global cognition.
variance explained in both groups (29.6%) (see also comparable
regression slopes for residuals in Figure 1). For PD, there was also a
significant association between more effective postural control with
better working memory explaining 16.3% of total variance, and
increased gait variability was significantly associated with lower
scores for global cognition, measured by the MoCA. For controls,
postural control was also associated with better attention although
only 6.5% of total variance in the model was explained. Relative to
controls, higherβ-values for PD for all associations were expressed.
Effect of motor phenotype
Associations were evident for the PIGD but not the TD pheno-
type. Partial correlations show a strong and positive relationship
between pace and attention, postural control and working mem-
ory, and rhythm was negatively correlated with executive function
showing that participants who walked with a faster cadence had
poorer executive function. These relationships held in the regres-
sion analysis where β-values for PIGD associations were stronger
than for PD or controls. Figure 1 shows a clear effect of motor phe-
notype, whereby the positive regression slope is steeper for PIGD
compared to TD.
DISCUSSION
To our knowledge this is the first study to comprehensively explore
the relationship between independent features of gait and cog-
nition in a large cohort of early PD. Our findings support a
significant association between cognition and gait with early stage
PD (n= 121), which differs with respect to healthy, age-matched
controls. The associations were dominated by the PIGD motor
phenotype. Importantly, gait impairments were sensitive to motor
phenotype discriminating between groups in contrast to cogni-
tive impairments suggesting that shared substrates have a different
temporal course. Longitudinal studies will verify the role of gait as
a surrogate biomarker of cognitive impairment in PD.
EARLY PD PATHOLOGY AND MOTOR PHENOTYPE: IMPACT ON GAIT
AND COGNITION
Gait was significantly different in PD compared to controls for 13
of the 16 gait characteristics we tested. Step velocity variability,
Table 5 | Summary of regression analyses for significant cognitive variables and gait domains for all participants.
Gait domain Cognitive domain β P Adjusted R2 ANOVA P
Control Pacea Attention 0.281 <0.001 0.296 F (5, 173)=15.4 <0.001
Visual memory 0.205 0.003
Postural controla Attention 0.183 0.018 0.065 F (4, 174)=4.1 0.003
PD (n=105a, n=115b) Pacea Attention 0.329 <0.001 0.296 F (5, 100)=9.8 <0.001
Working memory 0.256 0.007
Postural controla Working memory 0.332 0.001 0.163 F (4, 101)=6.1 <0.001
Variabilityb Global cognition (MoCA) 0.289 0.024 0.074 F (4, 107)=3.2 0.016
PIGD (n=55) Pacea Attention 0.423 0.003 0.196 F (4, 44)=3.9 0.008
Rhythma Executive function −0.468 0.010 0.141 F (4, 44)=2.7 0.041
Postural controla Working memory 0.321 0.029 0.236 F (4, 44)=4.7 0.003
aFor Model, gait domains were regressed on five cognitive domains: attention and fluctuating attention, visual memory, executive function, visuospatial function, and
working memory.
bFor Model, MoCA was the only cognitive variable entered. For all models age, sex, and years of education were entered in the first block.
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FIGURE 1 | Association between attention and pace domain of gait (z scores) for controls and PD (A) and PIGD andTD (B). *Denotes significance at
P <0.001. Age, sex, and NART entered as covariates.
swing time, and step width were not significantly different, sug-
gesting that these features are preserved at this early stage. Findings
from our study partly concur with the only other detailed examina-
tion of gait in early PD that we are aware of. Thirty five participants
with de novo PD (who were not defined by phenotype) showed a
significantly slower and more variable gait compared with con-
trols, along with a decrease in stride length and increase in stride
time, asymmetry, and double support time (Baltadjieva et al.,
2006).
Compared with the TD group, participants with PIGD phe-
notype were significantly slower and presented with a shorter
step length and increased variability of step timing and stance
timing. Between-group differences in gait variability were not
as strong as anticipated, given its sensitivity to early (Mirelman
et al., 2011) and established pathology (Hausdorff et al., 2003),
which may be partly due to testing protocol. We report find-
ings from single-task gait, and an increase in gait variability is
most often detected during stress testing, such as dual task or fast
walking conditions (Amboni et al., 2012). Cognitive outcomes
for PD were overall significantly worse than for controls, concur-
ring with earlier work (Muslimovic et al., 2005; Domellof et al.,
2011) and in agreement with those reported for the larger ICI-
CLE cohort (Yarnall et al., 2014). However, unlike motor impair-
ment, cognitive deficit was not significantly different between
phenotypes in this early cohort, as reported elsewhere (Mus-
limovic et al., 2005). Interestingly, semantic fluency was more
impaired in the PIGD group compared to the TD participants;
this test has been shown to predict future dementia in early PD
(Williams-Gray et al., 2007).
RELATIONSHIP BETWEEN GAIT AND COGNITION IN PD AND
CONTROLS: EVIDENCE FOR COMMON AND DISTINCT FEATURES
For control, PD, and PIGD participants the strongest and most
consistent associations were found for the pace domain of gait and
attention, which is underpinned by frontal and prefrontal activity
that are mediated by dopaminergic as well as cholinergic substrates
(Rochester et al., 2012). There may be different reasons for this.
Firstly, gait is a goal directed activity realized through activation of
attentional circuits,which project from dorsolateral prefrontal cor-
tex to the dorsolateral head of the caudate nucleus, with dopamine
and acetycholine involved in signaling at various levels of the cir-
cuit (Calabresi et al., 2006). Secondly, changes to motor control
occur early in PD as movement degrades from being responsive
and automatic to slow, and voluntary, thus, requiring compen-
satory cognitive (particularly attentional) effort (Redgrave et al.,
2010). We were surprised that the pace–attention relationship was
not evident for the TD phenotype given that it was significant for
controls. The reasons for this are unclear. We controlled for age
and sex in analysis, ruling out these as potential confounders. The
control group (n= 184) may have presented with higher levels
of vascular burden, which may subtly impact on the relationship,
however, this is speculative. Inspection of the slopes suggests a
similar trend for TD and controls, and we may have been under-
powered to detect a significant difference. Cognition also played
a consistent role in postural control for all participants; however,
this was underpinned by attention in controls and working mem-
ory in PD and PIGD phenotype. Attention made only a small
contribution in controls (6%) compared to working memory in
PD (16%), which increased in PIGD to 24%. Cognition, partic-
ularly attention and executive function, is known to contribute
to postural control in older adults with some evidence in PD
(Schoneburg et al., 2013). The role of working memory is interest-
ing. Working memory in this study was measured using the digit
span (forward), which also reflects short-term memory. Given that
its contribution to PD was dominated by the PIGD phenotype
this may reflect early changes in features consistent with amnes-
tic function although longitudinal studies are required to test this
hypothesis. Alternatively, it may reflect amyloid deposition, given
studies showing lower CSF amyloid in PIGD (Alves et al., 2013)
and negative correlation between memory scores and Aβ (Alves
et al., 2010).
Variability was associated with global cognition as reported in
older adults (Lord et al., 2013a; Verlinden et al., 2014) but surpris-
ingly not related to a specific cognitive domain. This is possibly due
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to the early disease presentation, and the association may become
more specific as disease advances.
PIGD PHENOTYPE DOMINATES THE RELATIONSHIP BETWEEN GAIT
AND COGNITION
Associations between gait and cognition were clearly different for
phenotype despite comparable cognitive outcomes, which allows
us to conjecture about the relationships we observed. If associa-
tions were due to co-incident gait/cognitive pathology, they would
be evident across the continuum of disease (albeit weaker for
TD), and not restricted to PIGD. An alternate explanation is that
attention and executive function were used to maintain gait per-
formance in people with PIGD, but not required to the same extent
in TD because gait is less impaired. Associations may also point to
a shared gait/cognition substrate for PIGD phenotype but not for
TD; however, longitudinal data are required to confirm this.
We were surprised to find that rhythm was inversely associated
with cognition (executive function) for PIGD given that it is pri-
marily considered a subcortical feature of gait mediated by spinal
and brainstem mechanisms and that values for rhythm character-
istics (step time, stance time, and swing time) were not sensitive
to motor phenotype in this early cohort. However, the rhythm
domain of gait has been shown to be sensitive to memory decline
in older adults (Verghese et al., 2007) and also to information
processing (Verlinden et al., 2014) suggesting that this is not an
aberrant finding.
Results from this study concur with our earlier work in more
advanced cohorts, which indicate a preferential contribution of
attention and executive function to gait, and a dominant effect
of dopaminergic medication on the relationship between cog-
nition and gait (Rochester et al., 2008; Lord et al., 2010). The
interaction between gait and cognition is complex because both
evolve and are likely to be associated differently over the course
of the disease. Gait domains that are strongly correlated with cog-
nition at baseline may not be predictive of future cognitive and
motor decline. Williams-Gray et al. (2007) identified the prognos-
tic strength of posterior cortical origin deficits (semantic fluency,
intersecting pentagons) for predicting dementia in PD, although
frontostriatal deficits were more striking at baseline. Results from
this study suggest that gait is more sensitive than cognition to PD
phenotype; however, longitudinal follow up of ICICLE-GAIT data
will map the evolution of gait and cognitive dysfunction as disease
progresses and identify the putative role of gait as a surrogate
biomarker for cognitive decline.
STUDY STRENGTHS AND LIMITATIONS
A key strength of this hypothesis-driven prospective study is
the recruitment of a well described community-representative
incident cohort and an age-matched control group. Limitations
include the small sample size for phenotype analysis and the fact
that not all PD participants were treatment-naïve, and the benefi-
cial effects of dopaminergic replacement therapy may have biased
results. We did not use a dual task testing paradigm because pre-
liminary analysis (not reported) found the dual task results to be
highly comparable to single task. This may be due in part to our
dual task testing protocol, which controls for baseline cognitive
capacity (Rochester et al., 2014), and as a result sensitivity may be
lower than previous reports, which have detected very early signals
for gait variability (Mirelman et al., 2011). The cognitive domains
we used in this study were not completely independent of each
other; for example, the correlation between attention and PRM
and SRM is highly significant, and this interdependence has to be
kept in mind when interpreting the results. We carried out a pre-
liminary principle component analysis for our cognitive variables
but were unable to identify discrete factors without cross-loadings,
and so rather than taking a data-driven approach we mapped
each cognitive outcome onto well-established domains. This also
ensured consilience with recently published work (Yarnall et al.,
2014). We did not include a language domain in our analysis.
The tests we used for language comprise single items from the
MoCA and MMSE and we did not find any convincing correla-
tions with gait in preliminary analysis. We did not report lastly,
we did not control for depression (GDS) in analysis that com-
pared PD and controls, although we have previously argued for
its association with gait possibly mediated via cognition (Lord
et al., 2013b). Analysis of our longitudinal data set will test this
hypothesis further.
CONCLUSION
Cognitive function is associated with gait in early PD, and this
association is driven by the PIGD motor phenotype. The associa-
tion is strongest for attentional control and pace and also includes
other cognitive and gait domains. Future analysis on this longitudi-
nal cohort will enhance understanding of the complex interaction
between gait and cognition in PD.
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